Legend Biotech Corp Stock Performance
| LEGN Stock | USD 50.00 0.26 0.52% |
The company secures a Beta (Market Risk) of -0.33, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Legend Biotech are expected to decrease at a much lower rate. During the bear market, Legend Biotech is likely to outperform the market. At this point, Legend Biotech Corp has a negative expected return of -0.0779%. Please make sure to verify Legend Biotech's jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to decide if Legend Biotech Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Legend Biotech Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Legend Biotech is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return 2.91 | Five Day Return 2.74 | Year To Date Return (14.96) | Ten Year Return 35.84 | All Time Return 35.84 |
1 | Is Legend Biotech Corporation a Good Growth Stock to Buy | 07/29/2024 |
2 | 08/08/2024 |
3 | Legend Biotech GAAP EPS of -0.05 beats by 0.21, revenue of 186.52M beats by 60.41M | 08/09/2024 |
4 | Heres What Analysts Are Forecasting For Legend Biotech Corporation After Its Second-Quarter Results | 08/14/2024 |
5 | GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients | 08/27/2024 |
6 | CARVYKTI is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as ... | 09/27/2024 |
7 | High Growth Tech Stocks To Watch In October 2024 | 10/01/2024 |
8 | Here are Tuesdays biggest analyst calls Nvidia, Tesla, Microsoft, Wells Fargo, Disney, Apple, First Solar more | 10/08/2024 |
| Begin Period Cash Flow | 787.3 M |
Legend |
Legend Biotech Relative Risk vs. Return Landscape
If you would invest 5,399 in Legend Biotech Corp on July 14, 2024 and sell it today you would lose (399.00) from holding Legend Biotech Corp or give up 7.39% of portfolio value over 90 days. Legend Biotech Corp is currently does not generate positive expected returns and assumes 2.9036% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Legend, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Legend Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Legend Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Legend Biotech Corp, and traders can use it to determine the average amount a Legend Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0268
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LEGN |
Estimated Market Risk
| 2.9 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Legend Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Legend Biotech by adding Legend Biotech to a well-diversified portfolio.
Legend Biotech Fundamentals Growth
Legend Stock prices reflect investors' perceptions of the future prospects and financial health of Legend Biotech, and Legend Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Legend Stock performance.
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.62) % | ||||
| Operating Margin | (0.23) % | ||||
| Current Valuation | 17.46 B | ||||
| Shares Outstanding | 184.29 M | ||||
| Price To Book | 7.77 X | ||||
| Price To Sales | 19.74 X | ||||
| Revenue | 285.14 M | ||||
| Gross Profit | (284.01 M) | ||||
| EBITDA | (421.76 M) | ||||
| Net Income | (518.25 M) | ||||
| Cash And Equivalents | 791.26 M | ||||
| Cash Per Share | 5.11 X | ||||
| Total Debt | 328.67 M | ||||
| Debt To Equity | 0.29 % | ||||
| Current Ratio | 3.83 X | ||||
| Book Value Per Share | 6.33 X | ||||
| Cash Flow From Operations | (384.47 M) | ||||
| Earnings Per Share | (1.54) X | ||||
| Market Capitalization | 9.26 B | ||||
| Total Asset | 1.85 B | ||||
| Retained Earnings | (1.48 B) | ||||
| Working Capital | 1.28 B | ||||
About Legend Biotech Performance
By examining Legend Biotech's fundamental ratios, stakeholders can obtain critical insights into Legend Biotech's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Legend Biotech is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 43.08 | 45.23 | |
| Return On Tangible Assets | (0.31) | (0.32) | |
| Return On Capital Employed | (0.27) | (0.28) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.41) | (0.43) |
Things to note about Legend Biotech Corp performance evaluation
Checking the ongoing alerts about Legend Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Legend Biotech Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Legend Biotech Corp generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 285.14 M. Net Loss for the year was (518.25 M) with loss before overhead, payroll, taxes, and interest of (284.01 M). | |
| Legend Biotech Corp currently holds about 791.26 M in cash with (384.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11. | |
| Latest headline from cnbc.com: Here are Tuesdays biggest analyst calls Nvidia, Tesla, Microsoft, Wells Fargo, Disney, Apple, First Solar more |
- Analyzing Legend Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Legend Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Legend Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Legend Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Legend Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Legend Biotech's stock. These opinions can provide insight into Legend Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.54) | Revenue Per Share 2.505 | Quarterly Revenue Growth 1.544 | Return On Assets (0.13) | Return On Equity (0.22) |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.